fbpx
Rabab Abou ElMagd Ahmed

Dr. Rabab Abou ElMagd Ahmed

MSc Pharm, PhD, SMBA Adjunct Clinical Professor at Department of Psychiatry, Faculty of Medicine & Dentistry, University of Alberta

Dr. Rabab Abou ElMagd Ahmed is currently working as an Adjunct Clinical Professor at the Department of Psychiatry, University of Alberta. She is also the member in the Association of Clinical Research Professionals (ACRP), Canadian Society for Hospital Pharmacists (CSHP), Canadian Pharmacist Association (CPhA), Japanese Society for Amino Acid Science (JSAAS), Vitamin Society of Japan (VSJ), and Japanese Biochemical Society (JBS).

Dr. Ahmed earned her M.Sc in Pharmaceutical Microbiology from Alexandria University in 2003. She obtained her Ph.D. in Neuropsychopharmacology, Enzyme Pathophysiology, and Pharmaceutical Biotechnology from the University of Tokushima, Japan in 2009 and completed her postdoctoral fellowship from Fuji-Otsuka Foundation. In 2015, Dr. Ahmed also completed an MBA course – “the Strategic Management of Innovation and Entrepreneurship” in Alberta School of Business, University of Alberta.

Through research and studies, Dr. Ahmed has gained her expertise in treatment guidelines, clinical research processes, managing clinical translational research and quality improvement projects in mental health. Secondly, she is an expert in design, development, and interpretation of clinical trials, HSR IRB – Biomedical and Social-Behavioral, FDA regulations, and GCP ICH. She also achieved her expertise in the areas of project management, change management, quality improvement, analytics, and business acumen with Scientist MBA accreditation and Lean Six Sigma Black Belt in Healthcare. As well, Dr. Ahmed has discovered a new etiology for schizophrenia and participated in developing a treatment for it, intensive knowledge in Neuropsychiatry and global mental health as a public health concern.

With more than 15 years of experience in evidence-based projects aimed at the identification of novel treatment strategies for different therapeutic areas include Neuropsychopharmacology and Oncology, Dr. Ahmed has over 50 publications.

Blended and in-person Classes on campus are starting from September 2021.

Apply Now

Latest updates

March 15, 2020 update – Bay River College Calgary Campus.